Biohappiness

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Biohappiness is the elevation of utility in humans through biological methods, including germline engineering through screening embryos with genes associated with a high level of happiness, or the use of drugs intended to raise baseline levels of happiness. The object is to facilitate the achievement of a state of "better than well."

Proponents of biohappiness include the philosophical abolitionist David Pearce, whose goal is to end the suffering of all sentient beings; and the Canadian ethicist Mark Alan Walker. Walker has sought to defend biohappiness on the grounds that happiness ought to be of interest to a wide range of moral theorists; and that hyperthymia, a state of high baseline happiness, is associated with better outcomes in health and human achievement.[1][2]

The concept of biohappiness also has its high-profile critics, including Leon Kass, who served on the President's Council on Bioethics during the presidency of George W. Bush.[3]

References[edit]

  1. ^ Mark Alan Walker, "In Praise of Biohappiness," IEET Monographs No. 2, December 2006, at ieet.org/archive/IEET-02-BioHappiness.pdf
  2. ^ Ronald Bailey, "Freezing or Uploading: Which Road to Immortality Would You Choose?" at http://reason.com/news/printer/121585.html
  3. ^ Leon Kass, "The Pursuit of Biohappiness," Washington Post, October 16, 2003, at http://www.aei.org/article/19300

External links[edit]

  • [1] David Pearce's homepage
  • [2] Beyond Therapy: Biotechnology and the Pursuit of Happiness (The President's Council on Bioethics, Washington, D.C., October 2003).

See also[edit]